Small HIV study tests safety of drug combo to wake up hidden virus
NCT ID NCT05230368
First seen Jan 27, 2026 · Last updated May 13, 2026 · Updated 18 times
Summary
This early-stage trial tested whether a combination of two HIV-1 inducers is safe for people with HIV subtype B who are on standard antiretroviral therapy and have undetectable virus levels. Nine men participated, and the study focused on monitoring side effects and serious adverse events. The goal was to gather safety data, not to treat or cure HIV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION, SUBTYPE B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Saint-Pierre
Brussels, 1000, Belgium
Conditions
Explore the condition pages connected to this study.